M codes: medical services and quality measures

482 codes, page 2 of 3.

Other codes in this group 200

Other codes in this group codes
CodeNameStatusHospitals with prices
HCPCS M1221Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; without evidence of retinopathyCurrent codenone yet
HCPCS M1222Glaucoma plan of care not documented, reason not otherwise specifiedCurrent codenone yet
HCPCS M1223Glaucoma plan of care documentedCurrent codenone yet
HCPCS M1224Intraocular pressure (iop) reduced by a value less than 20% from the pre-intervention levelCurrent codenone yet
HCPCS M1225Intraocular pressure (iop) reduced by a value of greater than or equal to 20% from the pre-intervention levelCurrent codenone yet
HCPCS M1226Iop measurement not documented, reason not otherwise specifiedCurrent codenone yet
HCPCS M1227Evidence-based therapy was prescribedCurrent codenone yet
HCPCS M1228Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody testCurrent codenone yet
HCPCS M1229Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infectionCurrent codenone yet
HCPCS M1230Patient has a reactive hcv antibody test and does not have a follow up hcv viral test, or patient has a reactive hcv antibody test and has a follow up hcv viral test that detects hcv viremia and is not referred to a clinician who treats hcv infection within 1 month and does not have hcv treatment initiated within 3 months of the reactive hcv antibody test, reason not givenCurrent codenone yet
HCPCS M1231Patient receives hcv antibody test with nonreactive resultCurrent codenone yet
HCPCS M1232Patient receives hcv antibody test with reactive resultCurrent codenone yet
HCPCS M1233Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not givenCurrent codenone yet
HCPCS M1234Patient has a reactive hcv antibody test, and has a follow up hcv viral test that does not detect hcv viremiaCurrent codenone yet
HCPCS M1235Documentation or patient report of hcv antibody test or hcv rna test which occurred prior to the performance periodCurrent codenone yet
HCPCS M1236Baseline mrs > 2Current codenone yet
HCPCS M1237Patient reason for not screening for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety (e.g., patient declined or other patient reasons)Current codenone yet
HCPCS M1238Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)Current codenone yet
HCPCS M1239Patient did not respond to the question of patient felt heard and understood by this provider and teamCurrent codenone yet
HCPCS M1240Patient did not respond to the question of patient felt this provider and team put my best interests first when making recommendations about my careCurrent codenone yet
HCPCS M1241Patient did not respond to the question of patient felt this provider and team saw me as a person, not just someone with a medical problemCurrent codenone yet
HCPCS M1242Patient did not respond to the question of patient felt this provider and team understood what is important to me in my lifeCurrent codenone yet
HCPCS M1243Patient provided a response other than "completely true" for the question of patient felt heard and understood by this provider and teamCurrent codenone yet
HCPCS M1244Patient provided a response other than "completely true" for the question of patient felt this provider and team put my best interests first when making recommendations about my careCurrent codenone yet
HCPCS M1245Patient provided a response other than "completely true" for the question of patient felt this provider and team saw me as a person, not just someone with a medical problemCurrent codenone yet
HCPCS M1246Patient provided a response other than "completely true" for the question of patient felt this provider and team understood what is important to me in my lifeCurrent codenone yet
HCPCS M1247Patient responded "completely true" for the question of patient felt this provider and team put my best interests first when making recommendations about my careCurrent codenone yet
HCPCS M1248Patient responded "completely true" for the question of patient felt this provider and team saw me as a person, not just someone with a medical problemCurrent codenone yet
HCPCS M1249Patient responded "completely true" for the question of patient felt this provider and team understood what is important to me in my lifeCurrent codenone yet
HCPCS M1250Patient responded as "completely true" for the question of patient felt heard and understood by this provider and teamCurrent codenone yet
HCPCS M1251Patients for whom a proxy completed the entire hu survey on their behalf for any reason (no patient involvement)Current codenone yet
HCPCS M1252Patients who did not complete at least one of the four patient experience hu survey items and return the hu survey within 60 days of the ambulatory palliative care visitCurrent codenone yet
HCPCS M1253Patients who respond on the patient experience hu survey that they did not receive care by the listed ambulatory palliative care provider in the last 60 days (disavowal)Current codenone yet
HCPCS M1254Patients who were deceased when the hu survey reached themCurrent codenone yet
HCPCS M1255Patients who have another reason for visiting the clinic [not prenatal or postpartum care] and have a positive pregnancy test but have not established the clinic as an ob provider (e.g., plan to terminate the pregnancy or seek prenatal services elsewhere)Current codenone yet
HCPCS M1256Prior history of known cvdCurrent codenone yet
HCPCS M1257Cvd risk assessment not performed or incomplete (e.g., cvd risk assessment was not documented), reason not otherwise specifiedCurrent codenone yet
HCPCS M1258Cvd risk assessment performed, have a documented calculated risk scoreCurrent codenone yet
HCPCS M1259Patient status documented within the first year of initiating dialysisCurrent codenone yet
HCPCS M1260Patient status not documented within the first year of initiating dialysisCurrent codenone yet
HCPCS M1261Patients that were on the kidney or kidney-pancreas waitlist prior to initiation of dialysisCurrent codenone yet
HCPCS M1262Patients who had a transplant prior to initiation of dialysisCurrent codenone yet
HCPCS M1263Patients in hospice on their initiation of dialysis date or during the month of evaluationCurrent codenone yet
HCPCS M1264Patients age 75 or older on their initiation of dialysis dateRetired codenone yet
HCPCS M1265Cms medical evidence form 2728 for dialysis patients: initial form completedCurrent codenone yet
HCPCS M1266Patients admitted to a skilled nursing facility (snf)Current codenone yet
HCPCS M1267Patients not observed in active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement periodCurrent codenone yet
HCPCS M1268Patients observed in active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement periodCurrent codenone yet
HCPCS M1269Receiving esrd mcp dialysis services by the provider on the last day of the reporting monthCurrent codenone yet
HCPCS M1270Patients not on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement periodCurrent codenone yet
HCPCS M1271Patients with dementia at any time prior to or during the monthCurrent codenone yet
HCPCS M1272Patients observed on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement periodCurrent codenone yet
HCPCS M1273Patients who were admitted to a skilled nursing facility (snf) within one year of dialysis initiation according to the cms-2728 formCurrent codenone yet
HCPCS M1274Patients who were admitted to a skilled nursing facility (snf) during the month of evaluation were excluded from that monthCurrent codenone yet
HCPCS M1275Patients determined to be in hospice were excluded from month of evaluation and the remainder of reporting periodCurrent codenone yet
HCPCS M1276Bmi documented outside normal parameters, no follow-up plan documented, no reason givenCurrent codenone yet
HCPCS M1277Colorectal cancer screening results documented and reviewedCurrent codenone yet
HCPCS M1278Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documentedCurrent codenone yet
HCPCS M1279Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not givenCurrent codenone yet
HCPCS M1280Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomyCurrent codenone yet
HCPCS M1281Blood pressure reading not documented, reason not givenCurrent codenone yet
HCPCS M1282Patient screened for tobacco use and identified as a tobacco non-userCurrent codenone yet
HCPCS M1283Patient screened for tobacco use and identified as a tobacco userCurrent codenone yet
HCPCS M1284Patients age 66 or older in institutional special needs plans (snp) or residing in long term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement periodCurrent codenone yet
HCPCS M1285Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specifiedCurrent codenone yet
HCPCS M1286Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reasonCurrent codenone yet
HCPCS M1287Bmi is documented below normal parameters and a follow-up plan is documentedCurrent codenone yet
HCPCS M1288Documented reason for not screening or recommending a follow-up for high blood pressureCurrent codenone yet
HCPCS M1289Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)Current codenone yet
HCPCS M1290Patient not eligible due to active diagnosis of hypertensionCurrent codenone yet
HCPCS M1291Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement periodCurrent codenone yet
HCPCS M1292Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement periodCurrent codenone yet
HCPCS M1293Bmi is documented above normal parameters and a follow-up plan is documentedCurrent codenone yet
HCPCS M1294Normal blood pressure reading documented, follow-up not requiredCurrent codenone yet
HCPCS M1295Patients with a diagnosis or past history of total colectomy or colorectal cancerCurrent codenone yet
HCPCS M1296Bmi is documented within normal parameters and no follow-up plan is requiredCurrent codenone yet
HCPCS M1297Bmi not documented due to medical reason or patient refusal of height or weight measurementCurrent codenone yet
HCPCS M1298Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounterCurrent codenone yet
HCPCS M1299Influenza immunization administered or previously receivedCurrent codenone yet
HCPCS M1300Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)Current codenone yet
HCPCS M1301Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)Current codenone yet
HCPCS M1302Screening, diagnostic, film digital or digital breast tomosynthesis (3d) mammography results documented and reviewedCurrent codenone yet
HCPCS M1303Hospice services provided to patient any time during the measurement periodCurrent codenone yet
HCPCS M1304Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement periodCurrent codenone yet
HCPCS M1305Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement periodCurrent codenone yet
HCPCS M1306Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement periodCurrent codenone yet
HCPCS M1307Documentation stating the patient has received or is currently receiving palliative or hospice careCurrent codenone yet
HCPCS M1308Influenza immunization was not administered, reason not givenCurrent codenone yet
HCPCS M1309Palliative care services provided to patient any time during the measurement periodCurrent codenone yet
HCPCS M1310Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco userCurrent codenone yet
HCPCS M1311Anaphylaxis due to the vaccine on or before the date of the encounterCurrent codenone yet
HCPCS M1312Patient not screened for tobacco useCurrent codenone yet
HCPCS M1313Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement periodCurrent codenone yet
HCPCS M1314Bmi not documented and no reason is givenCurrent codenone yet
HCPCS M1315Colorectal cancer screening results were not documented and reviewed; reason not otherwise specifiedCurrent codenone yet
HCPCS M1316Current tobacco non-userCurrent codenone yet
HCPCS M1317Patients who are counseled on connection with a csp and explicitly opt outCurrent codenone yet
HCPCS M1318Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a cspCurrent codenone yet
HCPCS M1319Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screeningCurrent codenone yet
HCPCS M1320Patients who screened positive for at least 1 of the 5 hrsnsCurrent codenone yet
HCPCS M1321Patients who were not seen within 7 weeks following the date of injection for follow up or who did not have a documented iop or no plan of care documented if the iop was >25 mm hgCurrent codenone yet
HCPCS M1322Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop =<25 mm hg for injected eyeCurrent codenone yet
HCPCS M1323Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documentedCurrent codenone yet
HCPCS M1324Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant)Current codenone yet
HCPCS M1325Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment)Current codenone yet
HCPCS M1326Patients with a diagnosis of hypotonyCurrent codenone yet
HCPCS M1327Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 8 weeksCurrent codenone yet
HCPCS M1328Patients with a diagnosis of acute vitreous hemorrhageCurrent codenone yet
HCPCS M1329Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounterCurrent codenone yet
HCPCS M1330Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)Current codenone yet
HCPCS M1331Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial examCurrent codenone yet
HCPCS M1332Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeksCurrent codenone yet
HCPCS M1333Acute vitreous hemorrhageCurrent codenone yet
HCPCS M1334Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounterCurrent codenone yet
HCPCS M1335Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)Current codenone yet
HCPCS M1336Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeksCurrent codenone yet
HCPCS M1337Acute pvdCurrent codenone yet
HCPCS M1338Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance periodCurrent codenone yet
HCPCS M1339Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance periodCurrent codenone yet
HCPCS M1340Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification periodCurrent codenone yet
HCPCS M1341Patients who did not have a follow-up assessment or did not have an assessment within 30 to 180 days after the index assessment during the performance periodCurrent codenone yet
HCPCS M1342Patients who died during the performance periodCurrent codenone yet
HCPCS M1343Patients who are at pam level 4 at baseline or patients who are flagged with extreme straight line response sets on the pam or with excessive missing responsesCurrent codenone yet
HCPCS M1344Patients who did not have a baseline pam score and/or a second score within 4 to 12 months of baseline pam scoreCurrent codenone yet
HCPCS M1345Patients who had a baseline pam score and a second score within 4 to 12 month of baseline pam scoreCurrent codenone yet
HCPCS M1346Patients who did not have a net increase in pam score of at least 6 points within a 4 to 12 month periodCurrent codenone yet
HCPCS M1347Patients who achieved a net increase in pam score of at least 3 points in a 4 to 12 month period (passing)Current codenone yet
HCPCS M1348Patients who achieved a net increase in pam score of at least 6-points in a 4 to 12 month period (excellent)Current codenone yet
HCPCS M1349Patients who did not have a net increase in pam score of at least 3 points within a 4 to 12 month periodCurrent codenone yet
HCPCS M1350Patients who had a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounterCurrent codenone yet
HCPCS M1351Patients who had a suicide safety plan initiated, reviewed, or updated and reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiationCurrent codenone yet
HCPCS M1352Suicidal ideation and/or behavior symptoms based on the c-ssrs or equivalent assessmentCurrent codenone yet
HCPCS M1353Patients who did not have a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounterCurrent codenone yet
HCPCS M1354Patients who did not have a suicide safety plan initiated, reviewed, or updated or reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiationCurrent codenone yet
HCPCS M1355Suicide risk based on their clinician's evaluation or a clinician-rated toolCurrent codenone yet
HCPCS M1356Patients who died during the measurement periodCurrent codenone yet
HCPCS M1357Patients who had a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessmentCurrent codenone yet
HCPCS M1358Patients who did not have a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessmentCurrent codenone yet
HCPCS M1359Index assessment during the denominator period when the suicidal ideation and/or behavior symptoms or increased suicide risk by clinician determination occurs and a non-zero c-ssrs score is obtainedCurrent codenone yet
HCPCS M1360Suicidal ideation and/or behavior symptoms based on the c-ssrsCurrent codenone yet
HCPCS M1361Suicide risk based on their clinician's evaluation or a clinician-rated toolCurrent codenone yet
HCPCS M1362Patients who died during the measurement periodCurrent codenone yet
HCPCS M1363Patients who did not have a follow-up assessment within 120 days of the index assessmentCurrent codenone yet
HCPCS M1364Calculated 10-year ascvd risk score of >= 20 percent during the performance periodCurrent codenone yet
HCPCS M1365Patient encounter during the performance period with hospice and palliative care specialty code 17Current codenone yet
HCPCS M1366Focusing on women's health mips value pathwayCurrent codenone yet
HCPCS M1367Quality care for the treatment of ear, nose, and throat disorders mips value pathwayCurrent codenone yet
HCPCS M1368Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathwayCurrent codenone yet
HCPCS M1369Quality care in mental health and substance use disorders mips value pathwayCurrent codenone yet
HCPCS M1370Rehabilitative support for musculoskeletal care mips value pathwayCurrent codenone yet
HCPCS M1371Most recent glycemic status assessment (hba1c or gmi) level < 7.0%Current codenone yet
HCPCS M1372Most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0%Current codenone yet
HCPCS M1373Most recent glycemic status assessment (hba1c or gmi) level >= 8.0% and <= 9.0%Current codenone yet
HCPCS M1374An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance periodCurrent codenone yet
HCPCS M1375An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance periodCurrent codenone yet
HCPCS M1376An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance periodCurrent codenone yet
HCPCS M1377Recommended follow-up interval for repeat colonoscopy of 10 years documented in colonoscopy report and communicated with patientCurrent codenone yet
HCPCS M1378Documentation of medical reason(s) for not recommending a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is >= 66 years old, or life expectancy < 10 years, other medical reasons)Current codenone yet
HCPCS M1379A 10 year follow-up interval for colonoscopy not recommended, reason not otherwise specifiedCurrent codenone yet
HCPCS M1380Filled at least two prescriptions during the performance period for any combination of the qualifying oral antipsychotic medications listed under "denominator note" or the long-acting injectable antipsychotic medications listed under "denominator note"Current codenone yet
HCPCS M1381Patients with secondary stroke (e.g., a subsequent stroke that may occur with vasospasm in the setting of subarachnoid hemorrhage) within 5 days of the initial procedureCurrent codenone yet
HCPCS M1382Patient encounter during the performance period with place of service code 11Current codenone yet
HCPCS M1383Acute pvdCurrent codenone yet
HCPCS M1384Patients who died during the performance periodCurrent codenone yet
HCPCS M1385Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-upCurrent codenone yet
HCPCS M1386Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance periodCurrent codenone yet
HCPCS M1387Patients who died during the performance periodCurrent codenone yet
HCPCS M1388Patients with documentation of an exam performed for recurrence of melanomaCurrent codenone yet
HCPCS M1390Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance periodCurrent codenone yet
HCPCS M1391All patients who were diagnosed with recurrent melanoma during the current performance periodCurrent codenone yet
HCPCS M1392Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)Current codenone yet
HCPCS M1393Patients who were not diagnosed with recurrent melanoma during the current performance periodCurrent codenone yet
HCPCS M1394Stages i-iii breast cancerCurrent codenone yet
HCPCS M1395Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or groupCurrent codenone yet
HCPCS M1396Patients on a therapeutic clinical trialCurrent codenone yet
HCPCS M1397Patients with recurrence/disease progressionCurrent codenone yet
HCPCS M1398Patients with baseline and follow-up promis surveys documented in the medical recordCurrent codenone yet
HCPCS M1399Patients who leave the practice during the follow-up periodCurrent codenone yet
HCPCS M1400Patients who died during the follow-up periodCurrent codenone yet
HCPCS M1401Stages i-iii breast cancerCurrent codenone yet
HCPCS M1402Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or groupCurrent codenone yet
HCPCS M1403Patients with baseline and follow-up promis surveys documented in the medical recordCurrent codenone yet
HCPCS M1404Patients on a therapeutic clinical trialCurrent codenone yet
HCPCS M1405Patients with recurrence/disease progressionCurrent codenone yet
HCPCS M1406Patients who leave the practice during the follow-up periodCurrent codenone yet
HCPCS M1407Patients who died during the follow-up periodCurrent codenone yet
HCPCS M1408Patients who have germline brca testing completed before diagnosis of epithelial ovarian, fallopian tube, or primary peritoneal cancerCurrent codenone yet
HCPCS M1409Patients who received germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosisCurrent codenone yet
HCPCS M1410Patients who did not have germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosisCurrent codenone yet
HCPCS M1411Currently on first-line immune checkpoint inhibitors without chemotherapyCurrent codenone yet
HCPCS M1412Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangementCurrent codenone yet
HCPCS M1413Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapyCurrent codenone yet
HCPCS M1414Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication)Current codenone yet
HCPCS M1415Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapyCurrent codenone yet
HCPCS M1416Patient received hospice services any time during the performance periodCurrent codenone yet
HCPCS M1417Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccinationCurrent codenone yet
HCPCS M1418Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination because of a medical contraindication documented by clinicianCurrent codenone yet
HCPCS M1419Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccinationCurrent codenone yet
HCPCS M1420Complete ophthalmologic care mips value pathwayCurrent codenone yet
HCPCS M1421Dermatological care mips value pathwayCurrent codenone yet